Catline Nobre

Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.

Y. Loriot, R. Flippot, C. Massard, 2023, European urology oncology.

NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK-Mutant Oncoproteins, Including Lorlatinib-Resistant Compound Mutations

A. Drilon, H. Pelish, M. Shair, 2024, Cancer discovery.